Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients.
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre la importancia, el cribado y la vacunación en pacientes con enfermedad inflamatoria intestinal.
Cribado
Enfermedad inflamatoria intestinal
Infección
Infection
Inflammatory bowel disease
Prevención
Prevention
Screening
Vaccination
Vacuna
Journal
Gastroenterologia y hepatologia
ISSN: 0210-5705
Titre abrégé: Gastroenterol Hepatol
Pays: Spain
ID NLM: 8406671
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
02
02
2022
revised:
22
03
2022
accepted:
28
03
2022
pubmed:
17
5
2022
medline:
29
11
2022
entrez:
16
5
2022
Statut:
ppublish
Résumé
Patients with inflammatory bowel disease (IBD) may require different immunosuppressive treatments throughout their illness. It is essential to assess the immunization status of patients at diagnosis or, if this is not possible, at least before the beginning of immunosuppressive therapy and, subsequently, administering the appropriate vaccines. Therefore, the aim of this work is to establish clear and concise recommendations on vaccination in patients with IBD in the different settings of our clinical practice including vaccination in children, during pregnancy, breastfeeding or on trips. This consensus document emphasises the differences between inactivated and attenuated vaccines and the different degrees of immunosuppression and correlates them with the administration of both mandatory and optional vaccines recommended to our patients with IBD. Finally, as a summary, 17 recommendations are established based on the available scientific evidence and expert opinion. A multidisciplinary team with extensive experience in IBD and vaccination, made up of specialists in gastroenterology, paediatrics, nursing and pharmacy, has participated in the preparation of these recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis.
Identifiants
pubmed: 35577225
pii: S0210-5705(22)00140-6
doi: 10.1016/j.gastrohep.2022.03.012
pii:
doi:
Substances chimiques
Immunosuppressive Agents
0
Types de publication
Practice Guideline
Journal Article
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
805-818Informations de copyright
Copyright © 2022 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.